Association between Cognitive Performance and Cortical Glucose Metabolism in Patients with Mild Alzheimer’s Disease
暂无分享,去创建一个
P. Bartenstein | A. Bokde | H. Hampel | A. Drzezga | M. Schwaiger | S. Teipel | G. Leinsinger | J. Thissen | C. Born | W. Dong | H. Moeller | M. Schwaiger | H. Hampel | G. Leinsinger | A. Drzezga | S.J. Teipel | A.L.W. Bokde | J. Thissen | W. Dong | C. Born | H.-J. Moeller | P. Bartenstein | G. Leinsinger | Peter Bartenstein | S. Teipel | Alexander Drzezga | Markus Schwaiger | H.-J. Moeller
[1] Kazunari Ishii,et al. Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography , 1997, European Journal of Nuclear Medicine.
[2] J. Talairach,et al. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .
[3] H. Mayberg,et al. Correction of PET Data for Partial Volume Effects in Human Cerebral Cortex by MR Imaging , 1990, Journal of computer assisted tomography.
[4] G. Alexander,et al. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study. , 1999, The American journal of psychiatry.
[5] G. Alexander,et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.
[6] P Pietrini,et al. Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation. , 1998, The American journal of psychiatry.
[7] J. Baron,et al. In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease , 2001, NeuroImage.
[8] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[9] J. Brandt,et al. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging , 1996, Neurology.
[10] G. Alexander,et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease , 1998, Neurology.
[11] S. DeKosky,et al. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.
[12] F. Fazio,et al. Impairment of Neocortical Metabolism Predicts Progression in Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.
[13] P Pietrini,et al. Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. , 1996, The American journal of psychiatry.
[14] D. Collins,et al. Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.
[15] R. Woods,et al. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. , 2001, Cerebral cortex.
[16] C. Grady,et al. Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer disease. , 1993, The International journal of neuroscience.
[17] M. Jüptner,et al. Review: Does Measurement of Regional Cerebral Blood Flow Reflect Synaptic Activity?—Implications for PET and fMRI , 1995, NeuroImage.
[18] Peter Herscovitch,et al. Correction of Positron Emission Tomography Data for Cerebral Atrophy , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[19] P Pietrini,et al. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] L. Sokoloff,et al. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. , 1981, Federation proceedings.
[21] J V Haxby,et al. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. , 1997, The American journal of psychiatry.